Should additional treatments (such as vitamin K or other agents) be initiated in patients with advanced liver disease and elevated INR and/or thrombocytopenia to prevent bleeding complications? With Dr Virginia Hernández-Gea.
Is there any association between Helicobacter pylori infection and gastroesophageal reflux disease (GERD)? Should patients be tested for H pylori and receive eradication treatment if the results are positive before initiating proton pump inhibitors (PPIs)? With Dr Paul Moayyedi.
What are the principles of diagnostic workup and treatment of diabetes in individuals with chronic pancreatitis? With Dr Marianna Arvanitakis.
When to refer patients with chronic pancreatitis for an endoscopic procedure (pancreatic duct stenting, pancreatic duct stone extraction)? With Dr Marianna Arvanitakis.
What are the principles of managing gastroesophageal reflux disease (GERD) in patients with obesity? With Dr Paul Moayyedi.
How to manage patients without signs or symptoms of gastroesophageal reflux disease (GERD) and with diagnosed Barrett esophagus (without dysplasia)? Should proton pump inhibitors (PPIs) be used long term? At what dose? With Dr Paul Moayyedi.
What tests should be performed in an individual with advanced liver disease (cirrhosis) prior to a scheduled low or moderate bleeding risk procedure, and how to prepare the patient for the procedure? With Dr Virginia Hernández-Gea.
How to monitor the effectiveness of oral pancreatic enzyme supplementation in patients with chronic pancreatitis? When to increase the dose? Can pancreatic enzymes be overdosed? If yes, what are the signs and symptoms? Does the overdosing pose a risk to the patient? With Dr Marianna Arvanitakis.
How to assess the nutritional status of patients with chronic pancreatitis and how to prevent malnutrition in such patients? With Dr Marianna Arvanitakis.
Should prokinetic agents be used in GERD? If so, in all or selected patients? With Dr Paul Moayyedi.
English
Polski
Español
українська